Skip to content

MEDELIOS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDELIOS

BE 1016.259.892
NACE 86.210, General medical practice
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€212,587
2024 · €51,866+€160,721
Equity
€267,953
2024 · €55,366+€212,587
Cash
€212,593
2024 · €50,446+€162,147
Balance sheet total
€339,194
2024 · €73,417+€265,776

Largest movements

2024 to 2025
Assets
  • Cash +€162,147

    up €162,147 (+321.4%), from €50,446 to €212,593

    mainly Net result for the year (+€212,587) and Tax, wage and social debts (+€51,855)

  • Current investments +€100,000

    new in 2025: €100,000

  • Tangible fixed assets +€3,485

    new in 2025: €3,485

Equity and liabilities
  • Profit (loss) carried forward +€212,587

    up €212,587 (+409.9%), from €51,866 to €264,453

  • Tax, wage and social debts +€51,855

    up €51,855 (+291.6%), from €17,786 to €69,640

    of which Taxes: +€49,116

Income statement
  • Gross operating margin +€208,373

    up €208,373 (+283.1%), from €73,601 to €281,974

  • Taxes +€49,215

    up €49,215 (+276.7%), from €17,786 to €67,001

  • Depreciation -€3,202

    down €3,202 (-93.2%), from €3,435 to €234

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €51,866
Gross operating margin +€208,373
Depreciation +€3,202
Other operating charges -€409
Financial income +€378
Financial charges -€1,608
Taxes -€49,215
Result 2025 €212,587

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€265,866
Investment -€103,719
Financing €0
Cash 2024 €50,446
Net result for the year +€212,587
Depreciation +€234
Receivables within one year +€755
Deferred charges and accrued income -€899
Trade debts +€1,335
Tax, wage and social debts +€51,855
Investment in fixed assets (net) -€3,719
Current investments -€100,000
Cash 2025 €212,593
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €73,417 €339,194 +€265,776 +362.0%
Fixed assets 21/28 - €3,485 +€3,485
Tangible fixed assets 22/27 - €3,485 +€3,485
Other tangible fixed assets 26 - €3,485 +€3,485
Current assets 29/58 €73,417 €335,709 +€262,291 +357.3%
Amounts receivable within one year 40/41 €1,358 €602 -€755 -55.6%
Other amounts receivable 41 €1,358 €602 -€755 -55.6%
Current investments 50/53 - €100,000 +€100,000
Cash at bank and in hand 54/58 €50,446 €212,593 +€162,147 +321.4%
Deferred charges and accrued income 490/1 €21,614 €22,513 +€899 +4.2%
Total equity and liabilities 10/49 €73,417 €339,194 +€265,776 +362.0%
Equity 10/15 €55,366 €267,953 +€212,587 +384.0%
Contributions 10/11 €3,500 €3,500 = 0.0%
Profit (loss) carried forward 14 €51,866 €264,453 +€212,587 +409.9%
Amounts payable 17/49 €18,051 €71,241 +€53,189 +294.7%
Amounts payable within one year 42/48 €18,051 €71,241 +€53,189 +294.7%
Trade debts 44 €266 €1,600 +€1,335 +502.6%
Suppliers 440/4 €266 €1,600 +€1,335 +502.6%
Taxes, remuneration and social security 45 €17,786 €69,640 +€51,855 +291.6%
Taxes 450/3 €17,786 €66,901 +€49,116 +276.2%
Remuneration and social security 454/9 - €2,739 +€2,739
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,435 €234 -€3,202 -93.2%
Other operating charges 640/8 €387 €796 +€409 +105.6%
Gross operating margin 9900 €73,601 €281,974 +€208,373 +283.1%
Operating profit (loss) 9901 €69,778 €280,944 +€211,165 +302.6%
Financial income 75/76B €7 €385 +€378 +5377.0%
Recurring financial income 75 €7 €385 +€378 +5377.0%
Financial charges 65/66B €133 €1,741 +€1,608 +1205.3%
Recurring financial charges 65 €133 €1,741 +€1,608 +1205.3%
Profit (loss) for the period before taxes 9903 €69,652 €279,587 +€209,936 +301.4%
Income taxes 67/77 €17,786 €67,001 +€49,215 +276.7%
Profit (loss) for the period 9904 €51,866 €212,587 +€160,721 +309.9%
Profit (loss) for the period to be appropriated 9905 €51,866 €212,587 +€160,721 +309.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.